PHP40 COST EFFECTIVENESS OF PATHOGEN INACTIVATION IN PLATELET TRANSFUSIONS
نویسندگان
چکیده
منابع مشابه
Economics of pathogen inactivation technology for platelet concentrates in Japan.
Residual risk of transmitting recognized and emerging blood-borne pathogens via blood transfusion in Japan persists despite advances in blood safety screening. The INTERCEPT Blood System (IBS) for platelets was developed to inactivate a broad spectrum of pathogens to reduce the risk of transfusion-transmitted infections. In this study we assessed the economic impact of the IBS on platelet trans...
متن کاملBacterial contamination of platelet concentrates: pathogen detection and inactivation methods
Whereas the reduction of transfusion related viral transmission has been a priority during the last decade, bacterial infection transmitted by transfusion still remains associated to a high morbidity and mortality, and constitutes the most frequent infectious risk of transfusion. This problem especially concerns platelet concentrates because of their favorable bacterial growth conditions. This ...
متن کاملTransfusion Medicine 2 Platelet transfusions
Ever since platelet transfusions were shown to reduce mortality from haemorrhage in patients with acute leukaemia in the 1950s, the use of this therapy has steadily grown to become an essential part of the treatment of cancer, haematological malignancies, marrow failure, and haematopoietic stem cell transplantation. Today, more than 1·5 million platelet products are transfused in the USA each y...
متن کاملPlatelet Transfusions to Alloimmunized Patients
either 1 patient at 1 month and 9 months after BMT, respectively, 2. Huges D, Hurd C, Williamson LM: Genotyping for human still exhibited the M-bcr rearrangement. platelet antigen-1 directly from dried blood spots on cards. Blood We conclude that mRNA extraction for diagnosis of the bcr-abl 88:3242, 1996 rearrangement in CML from dried blood spotted on filter paper is 3. McCabe ERB: DNA techniq...
متن کاملInfluence of HLA-A2 on the effectiveness of platelet transfusions in alloimmunized thrombocytopenic patients.
Platelet transfusions from donors selectively mismatched for cross-reactive and certain non-cross-reactive HLA antigens were found to be more effective in HLA-A2 negative than in HLA-A2 positive, alloimmunized thrombocytopenic patients. The two groups of patients responded equally well to platelets matched for antigens of the HLA-A and B loci. Certain alloimmunized patients negative for HLA-A2 ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Value in Health
سال: 2002
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)60900-x